With the passage of the Affordable Care Act followed by the physician payment reform, there is an urgent need to better understand the complex relationships between structure (including incentives), processes, and outcomes of health care and, based on this understanding, identify interventions that can ensure delivery of high-value care to patients with liver disease. As hepatologists, how do we systematically address these issues and ensure that we provide high-value care to our patients? These factors combine in the burgeoning field of health services research. This article seeks to describe how health services research influences the practice of hepatology, the tools and technologies it utilizes, as well as how interested individuals can seek to acquire knowledge and methodological training in health services research. Finally, we summarize the current state of health services research in hepatology and liver transplantation. (HEPATOLOGY 2018; W ith the passage of the Affordable Care Act (ACA) followed by the physician payment reform, there is an urgent need to better understand the complex relationships between structure (including incentives), processes, and outcomes of health care and, based on this understanding, identify interventions that can ensure delivery of highvalue care to patients with liver disease. Quality of health care refers to the degree to which health services for individuals and populations increase the likelihood of desired outcomes and is consistent with existing evidence and knowledge. Quality of care can be measured by measuring the structure, process, as well as outcomes of care; however, the traditional concept of quality is independent of cost of providing that care. High-value care balances quality with costs with the overarching goal of improving patient outcomes.
W ith the passage of the Affordable Care Act (ACA) followed by the physician payment reform, there is an urgent need to better understand the complex relationships between structure (including incentives), processes, and outcomes of health care and, based on this understanding, identify interventions that can ensure delivery of highvalue care to patients with liver disease. Quality of health care refers to the degree to which health services for individuals and populations increase the likelihood of desired outcomes and is consistent with existing evidence and knowledge. Quality of care can be measured by measuring the structure, process, as well as outcomes of care; however, the traditional concept of quality is independent of cost of providing that care. High-value care balances quality with costs with the overarching goal of improving patient outcomes. (1) As hepatologists, how do we systematically address and ensure that we not only provide high-quality care, but that we provide high-value care to our patients? These factors combine in the burgeoning field of health services research (HSR). This article seeks to describe how HSR influences the practice of hepatology, the tools and technologies it utilizes, as well as how interested individuals can seek to acquire knowledge and methodological training in HSR. Finally, we summarize the current state of HSR in hepatology and liver transplantation (LT).
biostatistics, epidemiology, health economics, medicine, nursing, operations research, psychology, and sociology. (2) The goal of HSR is to study how social factors, financing systems, organizational structures, health technologies, and personal behaviors affect the access to and outcomes (including quality and cost) of care provided by health care systems. (2) Ultimately, the discoveries of HSR are used to inform and evaluate health policy initiatives, such as changes in government-sponsored health insurance coverage (e.g., Medicare and Medicaid) or policies that address health care disparity on a local, regional, and national level. (3) In contrast to medical research, which focuses on the development and evaluation of clinical treatments, HSR is more concerned with delivery and access to those treatments in routine clinical care. Specifically, HSR examines the effectiveness of care, a different concept than the more familiar idea of efficacy. Efficacy describes how well a drug, procedure, or device improves clinical outcomes under ideal conditions. Often addressed by randomized controlled trials, efficacy estimates allow us to determine whether a therapy can, for example, suppress hepatitis C virus (HCV), relieve ascites, or increase survival under controlled circumstances. Effectiveness describes how the given intervention influences outcomes in day-to-day practice, accounting for differences in access, tolerability, and compliance to treatments. Unfortunately, there is often a wide chasm between efficacy and effectiveness; HSR addresses the reasons underling this disconnect with the goal of closing the gap between efficacy and effectiveness.
The measures of interest in HSR include more than just hard endpoints like survival, but extend to include the framework of structure, process, and outcome, (4) including cost-effectiveness of care. (5) The latter represents the concept of value, generally defined as "outcomes achieved per dollar spent," (1) and emphasizes the need to balance clinical interventions with cost, broadening the focus from acute disease management to include primary, secondary, or tertiary prevention, care coordination, and continuity. (4) The science of HSR includes the areas of (1) access, quality, and safety, (2) comparative evaluations of models of care delivery, (3) implementation of clinical practice guidelines and best practices in various care settings, (4) comparative effectiveness research (CER) on diagnostic tests and treatments, and (5) shared decision making and the development of patient-reported outcome measures based on pertinent stakeholder engagement (Table 1) . (2) Tools for Conducting HSR Health service interventions are inherently complex and usually involve multiple levels, including patients, providers, health care organizations, and community contexts. Although HSR relies on study designs that are widely used in other disciplines, including experimental (such as randomized controlled trials) and observational (such as retrospective cohort studies) designs, the ability to collect, study, and understand the disparate types of data at a population level requires new tools and a unique set of skills. This process is becoming easier with rapid advances in medical technology, which continue to fundamentally change the way HSR is performed. Tools such as the electronic medical record (EMR), clinical databases, and patient registries are examples of how technology can help address these questions in a quantitative manner. Such advances, however, require a new type of physician scientist, one who can understand and grapple with the complex challenges associated with EMR-based research: fragmented data structure, data standardization, electronic security, data management, and realtime analytics. (6) 
ARTICLE INFORMATION:
Given the breadth of questions that HSR attempts to address, there are numerous areas for methodological emphasis in HSR (Table 2 ). Several quantitative approaches in HSR may be familiar to many, including comparative effectiveness design, systemic reviews, and meta-analyses. However, numerous questions in HSR cannot be answered based on quantitative data alone. Thus, mixed-methods approaches (e.g., that which combine quantitative and qualitative data collective and analysis) are commonly used in HSR. Examples might include exploring barriers to hepatitis C treatment in substance users with patient and provider surveys and focus groups, examining why alcohol liver disease patients with cirrhosis do not maintain alcohol abstinence using AUDIT-C questionnaires and direct patient observations, or investigating what factors influence posttransplant medication adherence using population surveys and qualitative interviews of selected survey respondents. Combining quantitative and qualitative data collection and analyses in a mixedmethod approach allows researchers in health services to answer complex questions that could not be answered otherwise.
Training and Mentoring in HSR
Effective HSR involves obtaining advanced skills to utilize the tools, resources, and study designs unique to this field. A career development training plan in HSR can integrate (1) mentored research experience, (2) didactic coursework and structured training workshops, (3) experiential training in application of learned methodology, (4) engagement of institutional resources, and (5) participation in local and national scientific meetings. As with other disciplines, the identification of appropriate mentors to help oneself navigate the research enterprise process is critical for success in HSR. By its nature, HSR is an interdisciplinary science where collaborations between divisions (general internal medicine and gastroenterology), departments (medicine and surgery), and schools (medical and public health) occur frequently.
The successful investigator will develop a mentorship team comprised of experienced and knowledgeable advisors from a variety of fields to create an environment for conducting innovative research. The "translational" component of HSR occurs when such research is applied within the actual delivery systems where medical care is provided. This has increasingly been recognized as essential for understanding how to improve the value of our investments in health care.
Didactic coursework will focus on understanding systems health care, the framework for conducting health care-delivery research, and may include methodological training in specific areas of focus ( Table 2 ). Individuals may also choose to pursue formal advanced degrees in the science of health care delivery, biostatistics and epidemiology, public health, clinical investigation, or health care quality and patient safety (Table 3) . Over 79 institutions across the United States offer individual and dual-degree programs in health services research and/or public health (https://www.nlm.nih.gov/nichsr/hsruniv.html). These programs prepare physicians and clinical health professionals for careers in academic medicine and nonclinicians for careers in academia, health systems, and research and policy organizations. Degrees are typically completed in 2 years, and programs vary from in-residence to online-only with many offering hybrid models to accommodate the needs of busy practicing clinicians.
Residents and fellows-in-training may also want to investigate institutional-based funding opportunities for career development in HSR (Table 4 ). The (Table 4) . (3) The Agency for Healthcare Research and Quality (AHRQ) also has several mechanisms available for individuals to gain knowledge and experience in health care-delivery research. One of the AHRQ's long-standing funding opportunities, the Institutional Health Services Research Training Program Award (T32), provides advanced training to individuals with career interests in HSR (http://www.ahrq.gov/funding/traininggrants/grants/active/t32/t32.html). An estimated 75% of protected research time over a 2-year training period is required for these awards, and these awards are typically restricted to postgraduate physicians in training.
There are also multiple opportunities available for junior faculty and/or postdoctoral fellows interested in HSR (Table 4) . These include institutional awards in CER methodologies through the Patient Centered Outcomes Research Institute (PCORI) award (parent K12) and Mentored Clinical Scientist Research Career Development Awards through the National Institutes of Health (NIH; parent K01/K08/K23) or VA career development program. These awards typically range between 2 and 5 years in duration, require senior mentorship, and the candidate must commit to spending at least 75% of their time engaged in research activities. For more established investigators who are interested in broadening their research portfolio to include the science of HSR, both the NIH (parent K18; available at: https://www.ahrq.gov/pcor/ahrq-pcor-trust-fundtraining-projects/pcortf-tcdpa12115.html) and VA (available at: https://www.research.va.gov/funding/ cdp.cfm) offer awards for career enhancement. Finally, mid-to senior-level health professionals can apply in research teams for the Robert Wood Johnson Foundation (RWJF) Clinical Scholars Program (available at: http://clinicalscholarsnli.org/about/how-it-works/).
Funding HSR
Unlike the funding of most other areas of health research, the broad relevance of HSR results in funding opportunities through multiple agencies. AHRQ research addresses cross-cutting access, quality, and cost issues that are faced by the entire American health care system. Other funding sources seek to fund HSR HSR is a rapidly growing field within the disciplines of hepatology and LT. Over the past 7 years, publication volume in HSR has increased by 50% (Fig. 1) . Examples include examining the causes for hospital readmission for decompensated cirrhosis, (7, 8) assessing the impact of delayed referral for treating hepatocellular carcinoma (HCC) on survival, (9) and factors affecting center variation in health care utilization after LT (Table 1) . (10) Several innovative collaborations have also been established within and between institutions and in our professional societies with the collective goal of advancing the value of health care for patients with liver disease. For example, in 2008 an inter-and transdisciplinary health services and outcomes research team (Northwestern University, Transplant Outcomes Research, Collaborative), that leveraged institutional strengths in social science, engineering, and management disciplines, coupled with an internationally recognized transplant program, was established at Northwestern University in Chicago, Illinois, to expand HSR beyond secondary data analysis in LT. (11) In 2015, the American Association for the Study of Liver Diseases (AASLD) supported the development of the Public Health/Health Care Delivery Special Interest Group (SIG), "To bring together AASLD members with shared interests in health services research and practice, including: disease prevention and public health, access to care, population-based disease management, improving quality of healthcare delivery, health economics and health policy." The Public Health/Health Care Delivery SIG now counts over 200 members. (12) Finally, in 2016, the AASLD Practice Metrics Committee, charged with developing quality indicators for clinical practice in hepatology, was established. At the same time, the AASLD funded the multisite Cirrhosis Quality Collaborative to initiate a systematic effort in improving quality of cirrhosis care. (13) The continued changing landscape of our health care system has placed the spotlight on identifying and correcting the deficiencies in the delivery of care to patients with liver disease today. Thus, the need for training and retaining an emerging workforce of health services researchers in hepatology and LT has never been greater.
Personal Perspectives and Conclusions
Although the field of HSR is relatively new, we have had individual experiences in this area that have been informative. Both of us pursued formal research training through a master's degree program (clinical investigation [L.V.W.] and HSR [F.K.]), in which the tenets of clinical trial design, health systems organization, and basic statistical analysis were obtained. This training was then extensively supplemented by training in advanced epidemiology, mixed-methods research, and implementation science principles, providing a framework for translating clinical and epidemiological findings into clinical practice (e.g., translational epidemiology, T4!T3) for patients with liver disease. The HSR training was supported by the NIH-level individual (F32, K23) and institutional (KL2) awards for L.V.W. and by the VA Health Services Research and Development Program for F.K. The cornerstone of our success in HSR has been diverse mentorship and multidisciplinary research teams, which, importantly, have been comprised mainly of individuals outside of the discipline of hepatology. Combined, this has included content experts in internal medicine, cardiology, pediatrics, endocrinology, biostatistics, surgery, and health policy, in addition to methodological expertise in risk prediction, epidemiology, large data management, qualitative methods, guideline development, systematic reviews, meta-analyses, and implementation science. One challenge in conducting subspecialty HSR is that subspecialty conditions may not be viewed as high impact compared to problems that are applicable to the broader general medicine patient population. One exception to this rule is subspecialty HSR in oncology. In cancer research, HSR investigators have had remarkable success at grant funding and high-impact journal publications. (14) Thus, cancer research may prove to be a useful model for hepatology researchers interested in performing high-impact HSR. In fact, the global burden of cirrhosis and highly prevalent chronic liver diseases, such as nonalcoholic fatty liver disease (NAFLD), currently meet or exceed the burden of many common cancers (e.g., colorectal cancer). Furthermore, cirrhosis is a precancerous condition, which makes drawing parallels with cancer HSR possible.
HSR relies on the knowledge and understanding of a broad spectrum of research disciplines, and the field is growing as both public and private research funding increase. There is an increasing demand for health services researchers within hepatology and LT in order to meet the demand. Training in HSR should include the knowledge and skills needed to function effectively as a member of an interdisciplinary team and involve mentorship and experiential training within the health system in which one hopes to enact change. As of 2018, important advances have been made in the evaluation of health care delivery for patients with liver disease, though many unanswered questions remain. We encourage you to engage in the AASLD Public Health/Health Care Delivery SIG (aasld.org/sig) and join us in seeking to improve disease prevention and public health, access to care, population-based disease management, quality of health care delivery, health economics, and health policy for an increasing population of patients with liver disease.
